{{IndexTitle}}

{{ThisArticleTitle}}

{{CatTitle}} {{ArticleDate}}

Basic Information

TCI Co., Ltd was founded in 1980 and has 1,120 employees worldwide. In collaboration with our clients and partners, we have created many best-selling products worldwide over the past few decades. Every year, TCI produces hundreds of millions of tablets and capsules worth of dietary supplements, tens of millions of bottles of functional drinks, and millions of facial masks and cosmetic serums. Our products can be found in several dozen countries globally, joining and delighting the lives of hundreds of millions of people.

We are grateful to our clients for these achievements but feel more than ever the weight of responsibility upon our shoulders. We continuously develop more effective products and set "Join and Delight Consumer's Life" as our most important goal.

Company Profile

Company NameTCI Co., Ltd
Stock Code8436
MarketTPEx Listed Company
IndustryBiotechnology and Medical Care
Principle ActivitiesR&D and Manufacturing Services of Functional Foods and Skincare Products
Address8F, NO.187 Kang Chien Rd., Taipei, Taiwan R.O.C
Unified Business No.12292039
Date of Establishment22/08/1980
Date of Listing25/08/2011
Date of Listing12/09/2013
CapitalNTD 1,182,608,300
Common shares issued118,260,830 shares
ChairmanLIN, YUNG-HSIANG
General ManagerLIN, YUNG-HSIANG
SpokespersonAnita Chen
Telephone(02)8797-7811
Fax(02)7720-6691
Emailir@tci-bio.com
Phone(02)2361-1300
Fiscal Year_endDecember 31
AuditorsPricewaterhouseCoopers Taiwan
CPA(Chartered Public Accountant)1HSU, MING-CHUAN
CPA(Chartered Public Accountant)2WANG, KAO-HWA
Stock Transfer AgentFubon Securities

Company Structure

Listed on September 12th, 2013, TCI shares are traded on Taipei Exchange Market,under the ticker symbol 8436.

Our fiscal year ends on December 31th, same as the calendar year.

We release monthly sales results by the 10th of each month; first, second and third quarter's earnings reports within 45 days after the season ends, and annual reports within 3 months after the year ends.

Please refer to the Financial Information section or visit the Market Observation Post System.

As a fast growing company in the competitive nutraceutical industry, TCI's dividend policy stipulates that 30% to 80% of the profit should be distributed by ways of cash dividend, stock dividend or a combination of both, determined by the business developments, capital needs as well as long term interests of the shareholders. The Board of Directors recommends a dividend distribution and the proposal has to be approved at the annual general shareholder's meeting. TCI's historical dividend information can be found at the Dividend Payout section.

TCI announces related information regarding investor conferences on the Market Observation Post System as well as the Investor Conference section on the website.

Please contact the transfer agency department of Fubon Securities.
Address: 11F, No. 17, Xuchang St, Zhongzheng Dist, Taipei City, 100
Phone: +886-2-2361-1300
Fax: +886-2-2311-1400
Website: https://www.fubon.com/securities/agiotage/agiotage_01.htm